• Thurs news: GSK inks 2nd neuro pact in weeks. Teva episodic migraine trial. FDA clears AZ’s Imfinzi for aggressive lung cancer. Novartis fails to block generic Entresto. Nuvig gets immune drug funding. See more on our front page

Conmed

Anonymous board for Conmed
Replies
3
Views
257
anonymous
Replies
0
Views
423
anonymous
Replies
78
Views
38K
anonymous
Replies
2
Views
949
anonymous
Replies
1
Views
956
anonymous
Replies
2
Views
644
anonymous
Replies
2
Views
1K
anonymous
Replies
31
Views
15K
anonymous
  • Poll
Replies
8
Views
5K
anonymous
Replies
100
Views
27K
anonymous
Replies
4
Views
2K
anonymous
Replies
1
Views
1K
anonymous
Replies
1
Views
2K
anonymous
Replies
5
Views
3K
anonymous
Replies
9
Views
5K
anonymous
Replies
3
Views
2K
anonymous
Replies
7
Views
5K
anonymous